Genetic testing and informed consent.
OBJECTIVE
To discuss unique issues related to cancer predisposition genetic testing and informed consent.


METHODS
Published professional articles, review articles, research articles, clinical practice, position statements, websites, and textbooks.


CONCLUSIONS
The discovery of germline mutations that confer a predisposition for the development of cancer will continue. The provision of adequate information is central to the process of genetic counseling and testing so that individuals may give informed consent and make choices appropriate to their own specific circumstances.


CONCLUSIONS
The use of genetic information for the management of cancer will impact the practice of all oncology nurses in the coming years. Knowledge of genes that predispose for cancer and standards that delineate essential components of quality care during the informed consent process is vital.
Rieger
P T
PT
University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Pentz
R D
RD
D003219:Confidentiality; D005568:Forms and Records Control; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D007258:Informed Consent; D009859:Oncology Nursing; D011287:Prejudice; D014481:United States